Given our results suggesting that the activation of Akt and NF-κB may be involved in MEK inhibitor primary resistance in colorectal cancer cells, we investigated whether perifosine or dimethyl fumarate (DMF) could overcome MEK inhibitor primary resistance. The gene discussed is AKT1; the disease is colorectal cancer.